Clinical Trial Supply Chain Management
Vaccine Trials
Storage and distribution of clinical vaccine trials and treatments require a single-source provider whose agility and tailored solutions set the highest quality standards. As the clinical subsidiary of UPS Healthcare, Marken’s extensive global network provides an exceptional degree of flexibility and efficiency, implementing innovative strategies designed and built for current and future demand.
Only Marken delivers the end-to-end capabilities and expert oversight needed to seamlessly guide your program through each stage of the pharmaceutical journey. Our experts and customer service specialists are available to discuss your Vaccine Trial Storage Solution requirements. Contact us on +1-800-627-5361 (US) or email info@marken.com
Related resources
Sanofi and Marken Transform the Pharma Supply Chain
1 August 2023
Pharmaceutical supply chains are among the most complex supply chains. Even the slightest geopolitical, environmental and physical impact can have…
Fierce Biotech Webinar: Accelerate Your Central Lab Value Chain: Flexible Solutions to Reach Patients Faster
20 July 2023
With the ongoing complexities of clinical treatment journeys, central labs remain a vital component in the supply chain for developing…
Reshaping Decentralized Clinical Trials With Fit-For-Patient Solutions
20 June 2023
The need to rethink traditional models in recent years has led to a revolution in the way clinical trials are…
Clinical Supply Chain Strategies for Building Resilience
20 March 2023
To achieve supply chain resilience in today’s unpredictable environment, it is imperative to establish limitless flexibility and expertise capable of…
Revolutionizing Patient-Centric Supply Chains to Improve Vaccine Access.
7 February 2023
Global disruptions over the past several years have had an undeniable impact on the vaccine landscape, including research trends, risk…
Optimizing Clinical Storage and Distribution in an Era of Clinical Trial Transformation.
4 January 2023
Strategic storage and distribution are pivotal pieces in the orchestration of delivering lifesaving treatments to patients throughout the entire pharmaceutical…
Marken Successfully Safeguards the Viability of Pharmaceutical Samples Within 42 Hours
4 January 2023
The distribution of critical cell samples requires an agile strategy with contingency planning and regulatory expertise to ensure seamless delivery…
Happy Holidays from Marken
21 December 2022
At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…
Marken Overcomes Multiple Obstacles To Successfully Deliver Critical Stem Cell Samples Across The Globe
9 December 2022
Stem cell samples require extremely tight 24-hour turnaround times in order to be modified and processed for critical cell therapy…
Patient Centricity in Clinical Trials: Solutions for the Evolving Landscape
1 March 2022
Two years into the pandemic, it’s clear that decentralized clinical trials are here to stay. Approximately 70 percent of patients…
Decentralized Trial Logistics Requires Thoughtful Strategy.
22 September 2021
Outsourcing Pharma and Marken President Ariette van Strien discuss the complexity of decentralized trials and considerations for crafting a strategic…
Fortifying Logistics With Technology for Decentralized Trials.
11 August 2021
Contract Pharma and Wes Wheeler, President of UPS Healthcare, discuss the partnership between Marken and THREAD, a decentralized clinical trial…
Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.
Login and quick links